Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Devonian Health Group ( (TSE:GSD) ) is now available.
Devonian Health Group Inc. announced its participation in the ThinkEquity Conference in New York, where CEO Dr. André Boulet will present to institutional investors and analysts. Additionally, the company closed a non-brokered private placement, raising $334,500.33 to support working capital and research and development, subject to TSX Venture Exchange approval.
More about Devonian Health Group
Devonian Health Group Inc. is a biopharmaceutical company focused on developing innovative prescription drugs, particularly targeting inflammatory diseases.
Average Trading Volume: 21,953
Technical Sentiment Signal: Sell
Current Market Cap: C$37.06M
For detailed information about GSD stock, go to TipRanks’ Stock Analysis page.